Free Educational Webinar with Dr. Mary Ambach and Dr. Christopher Rogers
Join us and learn about Stem Cells, Platelet Rich Plasma (PRP) and other cell based therapies currently used for the treatment of joint pain caused by arthritis. Get answers to your questions from experts in the field of Regenerative Medicine.
Your hosts:
Dr. Mary Ambach specializes in non-surgical orthopedics, regenerative therapies and interventional pain management. As a key thought leader in the field of Regenerative Medicine, Dr. Ambach conducts research, trains physicians and lectures at international medical conferences.
Dr. Christopher Rogers is one of the world’s leading experts in orthopedic regenerative medicine and a renowned speaker at national medical conferences. He has developed new approaches for the treatment of tendon injuries, osteoarthritis and disc degeneration which provide a safe and viable alternative to surgery.
Dr. Christopher Rogers and colleagues are first to publish scientific review of stem cell therapy for COVID-19 patients.
Dr. Rogers, along with scientists from around the world, are first to publish a comprehensive scientific review, “Rationale for the Clinical Use of Adipose-derived Mesenchymal Stem Cells for COVID-19 patients.” Clinical trials of stem cell treatments for severe COVID-19 are currently being conducted at dozens of medical centers worldwide. Scientific studies will advance our understanding of the safety and efficacy of stem cell therapy for these seriously ill patients.
This scientific review was published in the peer-reviewed journal, Journal of Translational Medicine (Rogers, C.J., Harman, R.J., Bunnell, B.A. et al. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med 18, 203 (2020).
On May 6th, Dr. Mary A. Ambach presented a webinar on Regenerative Medicine for Orthopedic Conditions.
In this webinar, she explains how regenerative medicine therapies facilitate the body’s ability to heal itself.By using your own cells, these therapies reduce inflammation, decrease pain and stimulate healing of common orthopedic conditions.
Treatments that use orthobiologics, such as PRP or stem cells, will vary depending upon the specific needs of each patient.Similar to cooking a meal, the preparation of each treatment must be customized in order to achieve the best outcome. Dr. Ambach provides a detailed explanation of the different types of orthobiologic therapy and the scientific rationale behind their use.
This in-depth presentation is educational and informative for anyone who is interested in learning more about their regenerative medicine treatment options.
Please click here, if you would like to schedule an evaluation with one of our physicians at San Diego Orthobiologics Medical Group.
We have taken every precaution to ensure your safety. All patients will be carefully screened prior to their appointment. We will continue our telehealth services for those who prefer to stay at home.
Things to Know About Our Re-Opening
SDOMG provides the maximum protection against coronavirus:
Every person will be scanned with an infrared (no-touch) thermometer upon entry to the clinic. Staff are also tested throughout the day.Anyone who has a low-grade fever will not be permitted into the office.
All staff members wear masks to reduce the potential spread of the virus to patients.
All patients are required to wear mask during their clinic visit.
All surfaces are cleaned frequently with qualified antiviral disinfectants.
Common areas, including doorknobs, will be cleaned every 30 minutes.
We observe 6-foot social distancing in the entire office.
In order to minimize contact, only critical staff members will remain on-site.
Our Reception Area
We provide a virtual waiting room for those who prefer to wait in their vehicle.We will call you when your personal consultation room is available.
If you prefer to wait inside, our reception area provides 6 feet of space for each person.
We ask you to observe our One Patient / One Companion policy and ask that you do not bring more than one other person with you to your appointment.
Your companion can stay in your vehicle and will be called when your visit concludes.
Virtual Care and Telehealth Visits
We will continue telehealth visits to ensure that our patients get the continued care they need during this pandemic.The video conference visit allows you to talk with our doctors face to face in real time in the comfort of your own home.
Here’s a quick overview of what you need to know:
You can use any web-enabled device including smartphones, tablets, laptops and desktop computers.
Telehealth visits are available during our regular clinic hours from 9 am to 5 pm, Monday through Friday, however, availability may be limited depending upon the schedule.
Your virtual visit typically takes 15-30 minutes. It will begin promptly at the scheduled time.
The video visit may take a few minutes to set up. Our staff will help with your set up prior to your appointment if needed.
We are currently using Zoom for our Telehealth service.You will receive a link in your email prior to your appointment. You simply click on the link to get connected to the visit. If you are using Zoom for the first time, you may be asked to open an account and may be required to download the zoom app, both of which will take a few minutes to complete.
If Telehealth is not an option for you, a telephone visit can be scheduled. Please note, telephone visits may not be covered by your health insurance.
Please contact your provider to determine the cost for the visit. A deposit may be required depending upon your insurance coverage.
Please don’t hesitate to call us for any questions.
Call (760) 259-2324 to schedule your telehealth visit.
Dr. Mary A. Ambach Presents FREE Webinar on May 6th
When: Wednesday, May 6, 2020
Time: 12:00 pm PDT
Join us for a FREE webinar as Dr. Mary A. Ambach talks about regenerative cell therapies for orthopedic conditions, including osteoarthritis and tendon injuries. There will be an opportunity for participants to submit questions and have them answered by our presenting physician.
Dr. Mary Ambach specializes in nonsurgical orthopedics, regenerative injection therapies, and interventional pain management. As a key thought leader in the field of Regenerative Medicine, Dr. Ambach has published research, trained physicians, and presents at international medical conferences.
Dr. Chris Rogers and his team at San Diego Orthobiologics Medical Group in collaboration with Personalized Stem Cells (PSC), Inc. conduct stem cell research at their clinic in Carlsbad, California. As medical director and principal investigator for these FDA approved clinical trials, Dr. Rogers realizes the potential that stem cell therapy may have for COVID-19 patients.
Currently, Personalized Stem Cells, Inc. is awaiting FDA approval to start a new clinical trial in COVID-19 patients. Recently, they were asked by the White House Task Force to apply for an expedited FDA review of their application to treat COVID-19 patients with stem cells. In preclinical trials, stem cells have been shown to improve the lung damage and inflammation caused by viral pneumonia.
Conducting COVID-19 Stem Cell Research
Doctors based in China and Israel published positive outcomes following their stem cell treatments. Israeli doctors announced that seven patients with COVID-19 experienced 100% recovery following stem cell treatment. PSC has collaborators in Wuhan and Beijing, where similar results have been reported.
To expedite the mass production of stem cells, PSC teamed up with Calidi Biotherapeutics, a San Diego based company which provided the pre-tested master cell line. These cells facilitated fast and efficient manufacturing of more stem cells, which will allow patients to receive treatment more quickly.
Pending FDA approval, the first clinical trial will be held in San Diego in a few weeks. PSC will apply for compassionate use approval for national and international use as well. Compassionate use is a way for patients who are not eligible for clinical trials to receive treatment. These patients have serious or life-threatening illnesses for which other treatments are not available.
To expedite the mass production of stem cells, PSC teamed up with